---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-078439"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T09:15:30.017331+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Perspective Therapeutics annual meeting results: all director nominees elected, say-on-pay approved

## Summary
- All five director nominees elected; Frank Morich received 35.4M for and 17.1M withheld (33% withhold).
- Say-on-pay passed with 73.7% support (38.7M for, 13.7M against, 0.15M abstain), excluding 8.3M broker non-votes.
- Ratification of WithumSmith+Brown as auditor approved with 59.1M for, 1.6M against, 0.14M abstain.
- Quorum of 82.17% of 74,050,841 shares represented at the meeting.

## SEC filing metadata
- accession: 0000950170-25-078439
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000095017025078439/0000950170-25-078439-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000095017025078439/catx-20250528.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-078439
- JSON: https://secwatch.observer/filing/0000950170-25-078439.json
- Plain text: https://secwatch.observer/filing/0000950170-25-078439.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.